Use of thianecarboxamides as dgat inhibitors

Details Use of thianecarboxamides as dgat inhibitors Use of thianecarboxamides as dgat inhibitors

2007-09-18

2009-08-04

Weddington, Kevin E (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S255050, C514S256000, C514S909000

Reexamination Certificate

active

07569590

ABSTRACT:
The present application describes methods of treating obesity using DGAT-1 inhibitors according to Formula I:including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4and Z are described herein.

REFERENCES:
patent: 5491152 (1996-02-01), Wilde et al.
patent: WO 2005044250 (2005-05-01), None
Chung et al., “Inhibition of Diacylglycerol Acyltransferase by Betulinic Acid fromAlnus hirsuta”, Planta Medica, vol. 72, No. 3, pp. 267-269 (Feb. 2006).
Bell, R.M. et al., “Enzymes of Glycerolipid Synthesis in Eukaryotes”, Ann. Rev. Biochem., vol. 49, pp. 459-487 (1980).
Cases, S. et al., “Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members”, The Journal of Biological Chemistry, vol. 276, No. 42, pp. 38870-38876 (2001).
Cases, S. et al., “Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis”, Proc. Natl. Acad. Sci. USA, vol. 95, pp. 13018-13023 (1998).
Chen, H.C. et al., “DGAT and Triglyceride Synthesis: A New Target for Obesity Treatment?”, Trends Cardiovasc. Med., vol. 10, No. 5, pp. 188-192 (2000).
Chen, H.C. et al., “Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1”, The Journal of Clinical Investigation, vol. 109, No. 8, pp. 1049-1055 (2002).
Lehner, R. et al., “Biosynthesis of Triacylglycerols”, Prog. Lipid Res., vol. 35, No. 2, pp. 169-201 (1996).
Oelkers, P. et al., “Characterization of Two Human Genes Encoding Acyl Coenzyme A:Cholesterol Acyltransferase-related Enzymes”, The Journal of Biological Chemistry, vol. 273, No. 41, pp. 26765-26771 (1998).
Orland, M.D. et al., “Acyl coenzyme A dependent retinol esterification by acyl coenzyme A:diacylglycerol acyltransferase 1”, Biochimica et Biophysica Acta, vol. 1737, pp. 76-82 (2005).
Sliskovic, D.R. et al., Chapter 3: “ACAT Inhibitors: The Search for a Novel and Effective Treatment of Hypercholesterolemia and Atherosclerosis”, Progress in Medicinal Chemistry, vol. 39, Elsevier Science B.V., publ., King, F.D. et al., eds., pp. 121-171 (2002).
Smith, S.J. et al., “Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat”, Nature Genetics, vol. 25, pp. 87-90 (2000).
Stone, S.J. et al., “Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice”, The Journal of Biological Chemistry, vol. 279, No. 12, pp. 11767-11776 (2004).
Wilde, R.G. et al., “ACAT Inhibitors Derived from Hetero-Diels-Alder Cycloadducts of Thioaldehydes”, Bioorganic & Medicinal Chemistry, vol. 4, No. 9, pp. 1493-1513 (1996).

Affiliated with

Also associated with

Rating

Use of thianecarboxamides as dgat inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of thianecarboxamides as dgat inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thianecarboxamides as dgat inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4097152